Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
paolo tarantino
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Nov 2, 2023, 09:32 |
Dialogues
5min OncoDaily Updates with Chandler Park: Paolo Tarantino on the future of triple negative breast cancer with the IMPRESSIVE phase Ib/II BEGONIA study
[embed]https://www.youtube.com/watch?v=vSQg9swI61A&t=7s[/embed]
Oct 20, 2023, 20:02 |
Insight
10 ESMO23 breast cancer abstracts not to miss by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on Twitter: "ESMO23 will have…
Oct 19, 2023, 18:39 |
Blog
Paolo Tarantino: The BEGONIA ph1/2 trial ages like good wine
Quoting Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, on X/Twitter: “The BEGONIA ph1/2 trial…
Oct 16, 2023, 23:06 |
Opinion
Paolo Tarantino: Greatly enjoyed contributing to the ADC session at Targets23!
Paolo Tarantino, MD and Researcher at the European Institute of Oncology and Clinical Research Fellow at…
Oct 14, 2023, 22:16 |
Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
Oct 12, 2023, 02:36 |
Blog
Paolo Tarantino: Truly grateful for the kind invitation and incredibly warm welcome by the Argentinian and Patagonian associations of clinical oncology.
Quoting Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, on X/Twitter: "Truly…
Oct 6, 2023, 15:32 |
Blog
Paolo Tarantino: Bright days ahead for ESMO journals!
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: “Congrats to the…
Oct 2, 2023, 22:37 |
Insight
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
Sep 21, 2023, 04:05 |
Drugs
Paolo Tarantino: The longest follow up to date of a metastatic trastuzumab trial.
Paolo Tarantino, a clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight…
12
13
14
15
16
All:
206
Posts:
131 - 140
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube